Emery D L
CSIRO Division of Animal Production, McMaster Laboratory, Blacktown, N.S.W. Australia.
Vet Parasitol. 1996 Aug;64(1-2):31-45. doi: 10.1016/0304-4017(96)00968-5.
The 1990s have seen the culmination of decades of painstaking research with the registration and launch of Tickgard (Hoechst), a recombinant vaccine against Boophilus microplus, and the provisional registration of a Taenia ovis vaccine. Research continues to hold promise for immunological control of Echinococcus, Fasciola, Haemonchus, Trichostrongylus and Ostertagia. Blood-sucking parasites (e.g. ticks and H. contortus) are susceptible to control by vaccines containing 'novel' or 'concealed' antigens where serum antibodies in blood meals attack targets in the gut. Antibodies also provide protection in taeniid models, whereas the protective response to be sought in Fasciola remains unclear. More problematic are formulations and delivery strategies to induce expulsion of gastrointestinal nematodes, using vaccines containing recombinant 'conventional' antigens. The use of computer models to simulate vaccine efficacy in worm control and challenges to the concept of 'hypo-responsiveness' of young lambs will encourage cautious optimism and lively debate as to the prospects for integrated worm control using parasite vaccines. This review covers the aspirations, current success and problems faced by researchers in the parasite arena.
20世纪90年代见证了数十年艰苦研究的成果,即抗微小牛蜱的重组疫苗Tickgard(赫斯特公司生产)的注册与推出,以及绵羊绦虫疫苗的临时注册。对于棘球绦虫、片形吸虫、血矛线虫、毛圆线虫和奥斯特他线虫的免疫控制研究仍充满希望。吸血寄生虫(如蜱和捻转血矛线虫)对含有“新型”或“隐蔽”抗原的疫苗敏感,血餐中的血清抗体可攻击肠道中的靶标。抗体在绦虫模型中也提供保护,而对片形吸虫所寻求的保护性反应仍不清楚。更具问题的是使用含有重组“常规”抗原的疫苗诱导排出胃肠线虫的制剂和递送策略。利用计算机模型模拟疫苗在蠕虫控制中的效果以及对幼龄羔羊“低反应性”概念的挑战,将引发人们对使用寄生虫疫苗进行综合蠕虫控制前景的谨慎乐观态度和热烈辩论。本综述涵盖了寄生虫领域研究人员的期望、当前的成功以及面临的问题。